Medications for Inflammatory Bowel Disease
The information provided here is meant to give you a general idea about each of the medicines listed below. Only the most general side effects are included. Ask your doctor if you need to take any special precautions. Use each of these medicines only as recommended by your doctor and according to the instructions provided. If you have further questions about usage or side effects, contact your doctor.
Medicines are prescribed to help control inflammation and other symptoms.
Prescription Medications
Aminosalicylates (5-ASA)
- Sulfasalazine
- Mesalamine
- Balsalazide
- Olsalazine
- Rectal administration forms (Rowasa enema, Canasa suppository)
- Prednisone
- Methylprednisolone
- Budesonide
- Rectal administration forms (enema, suppository, foam)
- Azathioprine
- 6-mercaptopurine (6-MP)
- Methotrexate
- Cyclosporine
- Tacrolimus
- Metronidazole
- Ampicillin
- Ciprofloxacin
- Anti-tumor necrosis factor agents:
- Infliximab
- Adalimumab
- Certolizumab pegol
- Golimumab
- Integrin receptor antagonists:
- Natalizumab
- Vedolizumab
- Diphenoxylate-atropine
- Loperamide
- Codeine
Aminosalicylates
Common names include:
- Sulfasalazine
- Mesalamine
- Balsalazide
- Olsalazine
- Rectal administration forms (Rowasa enema, Canasa suppository)
Aminosalicylate drugs help control inflammation in the colon. Precisely how they work is unknown. The active ingredient is released after bacteria in the bowel metabolize the drug.
Possible side effects include:
- Nausea and vomiting
- Heartburn
- Diarrhea
- Headache
- Skin rash
Corticosteroids
Common names include:
- Prednisone
- Methylprednisolone
- Budesonide
- Rectal administration forms (enema, suppository, foam)
Corticosteroids reduce inflammation by suppressing the immune system. They are ordered for more severe episodes of inflammatory bowel disease. They may be taken by mouth, injected, or given by enema or suppository. Do not suddenly stop taking these medicines. Follow your doctor’s instructions for tapering the dose.
Possible side effects include:
- Increased risk of infection
- Weight gain
- High blood pressure
- Mood swings and depression
- Osteoporosis
- Acne
Immune Modifiers
Common names include:
- Azathioprine
- 6- mercaptopurine (6-MP)
- Methotrexate
- Cyclosporine
- Tacrolimus
Immune modifiers block the immune response that helps produce inflammation. These drugs take a long time (months) to work and are usually started with another, more fast-acting drug.
Possible side effects include:
- Bone marrow suppression
- Increased risk of infection
- Nausea and vomiting
- Diarrhea
Antibiotics
Common names include:
- Metronidazole
- Ampicillin
- Ciprofloxacin
Antibiotics are given to treat infections. In Crohn disease and ulcerative colitis, the bowel wall is more susceptible to infection once the lining of the small or large intestine is damaged. Infections are caused when bacteria penetrate the bowel wall. Antibiotics may also be prescribed before bowel surgery. Take antibiotics with food to decrease stomach upset. It is very important that you finish the complete course of therapy. Do not stop taking the antibiotics even if you feel better. Do not drink alcohol while taking antibiotics.
Possible side effects include:
- Upset stomach
- Diarrhea
- Vaginal yeast infections
- Bacterial colitis
Biologic Therapy
- Anti-tumor necrosis factor agents:
- Infliximab
- Adalimumab
- Certolizumab pegol
- Golimumab
- Integrin receptor antagonists:
- Natalizumab
- Vedolizumab
These drugs have been approved to treat severe disease that does not respond to other treatments. TNF-inhibitors is a genetically engineered antibody that binds specifically to tumor necrosis factor (TNF) and blocks its activity in the body. Infliximab is infused into a vein at prescribed intervals. Adalimumab and certolizumab can be given at home.
Integrin receptor antagonists block the effects of leucocytes (white blood cells that cause inflammation). They inhibit a protein that coats the leucocytes and keep them from moving into the tissues.
Possible side effects include:
- Difficulty breathing
- Hives
- Headache
- Infection
- Increased risk for children and teens to develop Hodgkin and non-Hodgkin lymphoma and other types of cancer
Antidiarrheals
Common names include:
- Diphenoxylate-atropine
- Loperamide
- Codeine
These drugs are given to manage diarrhea during active episodes of the disease. They slow movement through the intestines. Although loperamide in liquid form is available without a prescription, the prescription-only capsule form is used for the treatment of inflammatory bowel disease.
Possible side effects include:
- Drowsiness
- Constipation
Special Considerations
If you are taking medicines, follow these general guidelines:
- Take the medicine as directed. Do not change the amount or the schedule.
- Ask what side effects could occur. Report them to your doctor.
- Talk to your doctor before you stop taking any prescription medicine.
- Plan ahead for refills if you need them.
- Do not share your prescription medicine with anyone.
- Medicines can be dangerous when mixed. Talk to your doctor if you are taking more than one medicine, including over-the-counter products and supplements.
REFERENCES:
Crohn disease in adults. EBSCO DynaMed website. Available at:https://www.dynamed.com/condition/crohn-disease-in-adults. Updated May 16, 2018. Accessed December 21, 2018.
IBD. American Gastroenterological Association website. Available at: https://www.gastro.org/practice-guidance/gi-patient-center/topic/inflammatory-bowel-disease-ibd. Accessed December 21, 2018.
Types of medications for Crohn's disease and ulcerative colitis. Crohn's & Colitis Foundation of America website. Available at: http://www.crohnscolitisfoundation.org/resources/types-of-medications.html. Accessed December 21, 2018.
Ulcerative colitis in adults. EBSCO DynaMed website. Available at:https://www.dynamed.com/condition/ulcerative-colitis-in-adults. Updated October 26, 2018. Accessed December 21, 2018.
Zabana Y, Domènech E, et al. Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice. Aliment Pharmacol Ther. 2010;31(5):553-600.
Last reviewed September 2018 by EBSCO Medical Review BoardDaus Mahnke, MD Last Updated: 11/24/2020